跳至主要内容
临床试验/NCT04119297
NCT04119297已完成不适用

Effects of Cold Application and Heparinoid on Periorbital Edema and Ecchymosis After Craniotomy

Necmettin Erbakan University0 个研究点目标入组 90 人开始时间: 2009年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
90
主要终点
Periorbital edema

研究概览

简要总结

During surgery, blood leaking from damaged blood vessels spread to the periorbital area may cause periorbital edema and ecchymosis after anterior craniotomy. This study was carried out to determine the effects of the cold application and the local heparinoid on periorbital edema and ecchymosis after craniotomy.

详细描述

Periorbital edema and ecchymosis are common after anterior craniotomy. Periorbital edema and ecchymosis are not complications, they are natural outcomes of surgical trauma. However, periorbital edema prevents pupil examination and causes the patient to experience fear and anxiety with accompanying ecchymosis. Periorbital edema rate after anterior craniotomy was 36.8-100%, ecchymosis rate was 62.5%, and 30% of patients with edema did not have a pupil examination for the first 36 hours after craniotomy.The present study was carried out to determine the effects of the heparinoid creams and regular cold application performed using gel packs in controlling periorbital edema and ecchymosis after craniotomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

盲法说明

The random allocation cards was developed using a computer generated random number by a biostatistician who was not associated with the study. Group allocation was concealed using individual sealed opaque envelopes. As patients were enrolled in the study, the next envelope was extracted and the patients was assigned to the groups accordingly. When the patient was transferred from the operating theatre to the NICU or clinic, the nurse in the study (NA) assigned the patient to one of the groups according to the list in the envelope. Other investigator nurse (SY), two observer nurses (DG, YT), and all patients were blinded from group assignment. Also, all patients were blinded to all measurements and, the investigator and two observers were blinded to each other's measurements.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The eligible participants were those
  • who were aged 18 years and older
  • who had Glasgow Coma Scale score > 15
  • who had no mental and physical problems that interfere with communication
  • whose vital signs were normal
  • who had no ptosis
  • who volunteered to participate and signed the informed consent form

排除标准

  • The participants excluded from the study;
  • who had Glasgow Coma Scale score < 15
  • who died during surgery
  • ptosis formed after surgery
  • who refused to participate

研究组 & 干预措施

Control

Active Comparator

Routine care (Irregular cold application or gauze bandages wetted with isotonic solution or once daily heparinoid cream application) of the clinic was applied.

干预措施: Routine care (Other)

Cold application

Experimental

Cold application was applied for three days after craniotomy.

干预措施: Cold gel pack (Other)

Heparinoid group

Experimental

Heparinoid cream was applied for three days after craniotomy

干预措施: Heparinoids Topical Cream (Drug)

结局指标

主要结局

Periorbital edema

时间窗: Evaluation was performed twice a day for three days after craniotomy.

This edema defined as swelling around the eye was evaluated using the Kara \& Gokalan's Scale.

Periorbital ecchymosis

时间窗: Evaluation was performed twice a day for three days after craniotomy.

This ecchymosis is produced by blood tracking into periorbital tissues, causing blue or purple discoloration of the upper and lower eyelid. Evaluation was performed with using the Kara \& Gokalan's Scale.

次要结局

  • Periorbital superficial skin temperature(Skin temperature was measured every hour before and after cold application)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Serpil Yüksel

Assistant Professor

Necmettin Erbakan University

相似试验

Effects of Cold Application and Heparinoid on... | 临床试验